Navigation Links
New Clinical Trial Review: Leukemia Patients Treated by Bellicum Pharmaceuticals -- 91% remission, 94% Survival (median follow-up 301 Days) Source: Pluvia Research
Date:4/10/2017

April 10, 2017, a new clinical trial report released today compares the significance of historic results treating Acute Leukemia patients vs clinical trial data reported by Bellicum Pharmaceuticals (NASDAQ: BLCM). The clinical trial review was released by Pluvia Securities Research (PSR).

The report reviews data from 122 malignant and non-malignant patients treated with BPX-501 (Bellicum Pharmaceuticals, clinical trial identifier NCT01865617 & NCT02065869). Leukemia patients treated by Bellicum, (n=35) had an overall survival rate of 94% at 6 months compared to a historical 6 month leukemia survival rate of 78% (source: National Donor Marrow Program)

56 patients with non-malignant blood disorders are also treated in the Bellicum trial. These include patients with Sickle Cell disease, Thalassemia Major and Wiscott-Aldrich. The report issued by PSR compares historical survival of these diseases at 1yr (82-92%) with 100% survival of patients treated by Bellicum BPX-501.

The full PSR Clinical Trial Review of Bellicum BPX-501 is available for free download (here)

For Additional Information Contact:
Steve Pluvia
Pluvia Research
801.824.1549

Read the full story at http://www.prweb.com/releases/2017/04/prweb14229071.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Allegheny Health Network Clinical Trial Examines Regorafenib as Maintenance Therapy for Colon Cancer
2. DrugDev Thought Leaders Share Experience and Insights on How Transformative Technology Improves Clinical Trials at Premier Pharma and Biotech Industry Conferences in Q2
3. Catalent Expands Kansas City Clinical Storage and Secondary Packaging Capabilities to Meet Growing Demand for Cold Chain Services
4. New DrugDev Educational Webinar Reveals How Biotechs and Smaller Pharmaceutical Companies Gain Site Attention and Engagement by Optimizing Clinical Trial Payments
5. FDAnews Announces — Medical Device Clinical Evaluation Reports: Complying with European Guidelines and the New MEDDEV 2.7/1 Rev. 4 Guidance Webinar, April 4, 2017
6. Catalent Wins Prestigious Clinical Supply Chain Excellence Award at BioPharma Asia Convention
7. Intrinsic Imaging Awarded Phase II Immuno-Oncology Clinical Trial for the Treatment of Non-Small Cell Lung Cancer and Small Cell Lung Cancer
8. Challenges and Innovation in Clinical Trial Supply to be Presented by Catalent Experts at Upcoming Conferences
9. Peanut Patch Continues to Show Promise in Extension of Latest Clinical Trial
10. New Clinical Data on Cryoablation For The Treatment Of Early Stage Breast Cancer To Be Presented At Susan G. Komen San Diego
11. ERT Clinical Trial Oversight Selected by Premier Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2019)... SCOTCH PLAINS, N.J. (PRWEB) , ... January 14, 2019 , ... NJ Top Docs Proudly Presents All Reviewed & Approved Living Well Providers of 2019. ... Iverson - Paramus , Dr. Edward Izrailov - Maplewood , Dr. Joanna Jodar ... Princeton , Dr. Robert Lenahan - Point Pleasant , Dr. Robert J. Reinhardt ...
(Date:1/13/2019)... HARRISBURG, Pa. (PRWEB) , ... January 12, 2019 ... ... (PATS) Young Professionals Committee (YPC) in conjunction with Temple University hosted a continuing ... Between Mentors and Mentees. The event aimed to create a series of ...
(Date:1/11/2019)... MINNEAPOLIS (PRWEB) , ... January 11, 2019 , ... ... announced the three finalist teams in its “Next Generation Captive Insurance Solutions for ... by Strategic Risk Solutions. , The three finalist teams are: , ...
(Date:1/10/2019)... ... January 10, 2019 , ... Mount Sinai Health ... Society at the United Nations Staff Recreation Council in support of the Helen ... complementary services including music, art, massage, and pet therapies to increase the comfort ...
(Date:1/10/2019)... FORT LAUDERDALE, Fla. (PRWEB) , ... January 10, ... ... the Beauty Industry by introducing their Cellulose Tencel CBD Infused Face Mask. CBD, ... a multitude of beneficial properties research has shown that CBD influences receptors that ...
Breaking Medicine News(10 mins):
(Date:1/15/2019)... ... January 15, 2019 , ... ... the largest faith-based nonprofit health system in North Texas, deployed MDsyncNET’s physician ... Co-Founder and CEO Brad Goldsmith, “We’re committed to providing Texas Health Resources ...
(Date:1/14/2019)... ... January 15, 2019 , ... Sigma Theta Tau International Honor Society of Nursing ... Awards. These awards are regarded as one of the most important and prestigious designations ... of the Year competition has recognized Sigma for the last 10 consecutive years. , ...
(Date:1/11/2019)... , ... January 11, 2019 , ... According to research, ... Top Acupuncture , people are now able to receive the respiratory treatment they ... We focus on the root causes of imbalance as well. Acupuncture and Chinese Medicine ...
Breaking Medicine Technology: